Telesurgery and remote surgery research: a bibliometric analysis of scientific growth, collaboration, and thematic evolution

Telesurgery and remote surgery have gained relevance in surgical innovation due to advances in robotics, telepresence, artificial intelligence, and high-speed communication networks. Despite this progress, the global evolution, collaborative structure, and thematic development of this field remain insufficiently characterized. A bibliometric study was conducted using records retrieved from Web of Science. Publications on telesurgery and remote surgery published up to 2025 were included. Bibliographic data were processed and analyzed using the bibliometrix package in R. Bibliometric indicators, citation metrics, country productivity, journal output, author contributions, collaboration networks, and keyword-based thematic patterns were assessed. A total of 476 publications on telesurgery were included, distributed across 290 journals. Scientific production showed sustained growth, with an annual growth rate of 20.59%, a mean document age of 6.06 years, and peak output in 2024. The average citation count was 28.54 citations per document. The United States and China were the leading contributors, with 151 and 120 publications, respectively, and also acted as the main hubs in the international collaboration network. The most cited studies focused on telerobotic systems for minimally invasive surgery, telerobotic neurovascular interventions, and ultra-reliable low-latency communications. Keyword analysis showed a progressive shift from early clinical feasibility and surgical applications toward connectivity, latency, robotic systems, extended reality, blockchain, and artificial intelligence. These trends indicate the transition of telesurgery from a clinically exploratory field to a technology-driven research domain. Telesurgery and remote surgery constitute a rapidly expanding and technologically driven research field. Future progress will require stronger international collaboration, real-world clinical validation, standardized outcome assessment, and strategies to reduce technological inequities across regions.